These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 4838006)

  • 1. Dialysis bone disease. A quantitative histologic study.
    Binswanger U; Sherrard D; Rich C; Curtis FK
    Nephron; 1974; 12(1):1-9. PubMed ID: 4838006
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of dialysate calcium and fluoride on bone disease during regular hemodialysis.
    Jowsey J; Johnson WJ; Taves DR; Kelly PJ
    J Lab Clin Med; 1972 Feb; 79(2):204-14. PubMed ID: 5009710
    [No Abstract]   [Full Text] [Related]  

  • 3. Hyperparathyroidism in chronic renal failure and dialysis osteodystrophy.
    O'Riordan JL; Page J; Kerr DN; Walls J; Moorhead J; Crockett RE; Franz H; Ritz E
    Q J Med; 1970 Jul; 39(155):359-76. PubMed ID: 5478506
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of haemodialysis on bone in chronic renal failure.
    Bishop MC; Woods CG; Oliver DO; Ledingham JG; Smith R; Tibbutt DA
    Br Med J; 1972 Sep; 3(5828):664-7. PubMed ID: 4650845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Radiological, biochemical and clinical aspects of uremic osteopathy in patients with long term dialysis].
    Frey FJ; Jonutis AJ; Bergstein Z; Hodler J; Flury W
    Schweiz Med Wochenschr; 1976 Oct; 106(42):1438-46. PubMed ID: 1006271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disordered calcium and phosphorus metabolism during maintenance hemodialysis. Correlation of clinical, roentgenographic and biochemical changes.
    Parfitt AM; Massry SG; Winfield AC; DePalma JR; Gordon A
    Am J Med; 1971 Sep; 51(3):319-30. PubMed ID: 5115990
    [No Abstract]   [Full Text] [Related]  

  • 7. Plasma calcium and magnesium fractions in chronic-renal-failure patients on maintenance haemodialysis.
    Varghese Z; Moorhead JF; Wills MR
    Lancet; 1973 Nov; 302(7836):985-8. PubMed ID: 4127276
    [No Abstract]   [Full Text] [Related]  

  • 8. Bone disease in patients dialyzed with untreated water.
    Rashid A; Posen GA; Gray D; Jaworski ZF
    Med Instrum; 1974; 8(3):204-6. PubMed ID: 4838450
    [No Abstract]   [Full Text] [Related]  

  • 9. [Evolution of bone lesions in repeated hemodialysis].
    Meyrier A; Marsac J; Billard D; Richet G
    Ann Med Interne (Paris); 1973 Feb; 124(2):85-90. PubMed ID: 4723746
    [No Abstract]   [Full Text] [Related]  

  • 10. Non-protein-bound hydroxyproline in plasma in renal bone disease.
    Bishop MC; Smith R
    Clin Chim Acta; 1971 Jul; 33(2):403-8. PubMed ID: 5119316
    [No Abstract]   [Full Text] [Related]  

  • 11. Calcium and phosphorus metabolism and bone disease in uremia.
    Kleeman CR; Massry SG; Coburn JW; Popovtzer MM
    Clin Orthop Relat Res; 1970; 68():210-37. PubMed ID: 4905786
    [No Abstract]   [Full Text] [Related]  

  • 12. Osteopenia and fractures occurring during maintenance hemodialysis. A new form of renal osteodystrophy.
    Parfitt AM; Massry SG; Winfield AC
    Clin Orthop Relat Res; 1972 Sep; 87():287-302. PubMed ID: 5078040
    [No Abstract]   [Full Text] [Related]  

  • 13. A controlled evaluation of clinical and metabolic effects of dialysate calcium levels during regular hemodialysis.
    Mirahmadi KS; Duffy BS; Shinaberger JH; Jowsey J; Massry SG; Coburn JW
    Trans Am Soc Artif Intern Organs; 1971; 17():118-24. PubMed ID: 5158077
    [No Abstract]   [Full Text] [Related]  

  • 14. Bone disease in hemodialysis patients with particular reference to the effect of fluoride.
    Cordy PE; Gagnon R; Taves DR; Kaye M
    Trans Am Soc Artif Intern Organs; 1974; 20A():197-202. PubMed ID: 4450338
    [No Abstract]   [Full Text] [Related]  

  • 15. Bone abnormalities after gastric surgery. A prospective histological study.
    Garrick R; Ireland AW; Posen S
    Ann Intern Med; 1971 Aug; 75(2):221-5. PubMed ID: 5558649
    [No Abstract]   [Full Text] [Related]  

  • 16. Metabolic bone disease in chronic renal failure. I. Dialyzed uremics.
    Huffer WE; Kuzela D; Popovtzer MM
    Am J Pathol; 1975 Mar; 78(3):365-84. PubMed ID: 1119535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Serum calcium, phosphorus and alkaline phosphatase as indicators in the therapy of renal osteodystrophy].
    Labos I; Kovacević M
    Med Arh; 1988; 42(4):181-5. PubMed ID: 3270761
    [No Abstract]   [Full Text] [Related]  

  • 18. Aluminum-associated bone disease in chronic renal failure: high prevalence in a long-term dialysis population.
    Andress DL; Maloney NA; Endres DB; Sherrard DJ
    J Bone Miner Res; 1986 Oct; 1(5):391-8. PubMed ID: 3503554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relation of age and sex to distribution of values in healthy adults of serum calcium, inorganic phosphorus, magnesium, alkaline phosphatase, total proteins, albumin, and blood urea.
    Keating FR; Jones JD; Elveback LR; Randall RV
    J Lab Clin Med; 1969 May; 73(5):825-34. PubMed ID: 5779266
    [No Abstract]   [Full Text] [Related]  

  • 20. Bone disease and soft tissue calcification in chronic peritoneal dialysis.
    Cangiano JL; Ramírez-González RE; Ramírez-Muxó O
    Am J Med Sci; 1972 Oct; 264(4):301-6. PubMed ID: 4647391
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.